Signal Advisors Wealth LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Signal Advisors Wealth LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,800 shares of the medical equipment provider’s stock after buying an additional 206 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Intuitive Surgical were worth $891,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. Vest Financial LLC raised its stake in shares of Intuitive Surgical by 73.5% during the 1st quarter. Vest Financial LLC now owns 4,728 shares of the medical equipment provider’s stock valued at $2,342,000 after buying an additional 2,003 shares during the last quarter. Arthur M. Cohen & Associates LLC grew its holdings in Intuitive Surgical by 1.9% during the first quarter. Arthur M. Cohen & Associates LLC now owns 10,541 shares of the medical equipment provider’s stock worth $5,221,000 after acquiring an additional 201 shares during the period. Thurston Springer Miller Herd & Titak Inc. raised its position in Intuitive Surgical by 19.8% during the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,292 shares of the medical equipment provider’s stock valued at $1,135,000 after acquiring an additional 379 shares in the last quarter. Clare Market Investments LLC lifted its holdings in Intuitive Surgical by 22.5% in the first quarter. Clare Market Investments LLC now owns 5,932 shares of the medical equipment provider’s stock valued at $2,938,000 after acquiring an additional 1,088 shares during the period. Finally, Portside Wealth Group LLC boosted its position in Intuitive Surgical by 17.0% in the 1st quarter. Portside Wealth Group LLC now owns 1,356 shares of the medical equipment provider’s stock worth $708,000 after purchasing an additional 197 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares in the company, valued at $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 25,443 shares of company stock worth $12,692,195. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Robert W. Baird cut their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday. Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler cut their price target on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research note on Wednesday, April 23rd. Finally, Evercore ISI reduced their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a report on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $596.05.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $557.08 on Friday. The business has a fifty day moving average price of $521.99 and a 200 day moving average price of $539.26. The company has a market cap of $199.67 billion, a P/E ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a one year low of $413.52 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the business earned $1.50 earnings per share. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.